gliclazide and Coronary Stenosis

gliclazide has been researched along with Coronary Stenosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bochaton-Piallat, ML; Brisset, AC; Chadjichristos, CE; Derouette, JP; Kwak, BR; Morel, S; Roth, I; Sutter, E	1

Other Studies

1 other study(ies) available for gliclazide and Coronary Stenosis

Article	Year
Targeting connexin 43 prevents platelet-derived growth factor-BB-induced phenotypic change in porcine coronary artery smooth muscle cells. Circulation research, 2008, Mar-28, Volume: 102, Issue:6 Topics: Actins; Animals; Becaplermin; Cell Differentiation; Cell Movement; Cell Shape; Cells, Cultured; Connexin 43; Connexins; Coronary Stenosis; Coronary Vessels; Disease Models, Animal; Female; Gap Junction alpha-5 Protein; Gap Junctions; Glycyrrhetinic Acid; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Peptides; Phenotype; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Recombinant Proteins; RNA Interference; RNA, Small Interfering; S100 Proteins; Signal Transduction; Stents; Sus scrofa; Time Factors; Tunica Intima	2008

Article

Year

Targeting connexin 43 prevents platelet-derived growth factor-BB-induced phenotypic change in porcine coronary artery smooth muscle cells.

Circulation research, 2008, Mar-28, Volume: 102, Issue:6

Topics: Actins; Animals; Becaplermin; Cell Differentiation; Cell Movement; Cell Shape; Cells, Cultured; Connexin 43; Connexins; Coronary Stenosis; Coronary Vessels; Disease Models, Animal; Female; Gap Junction alpha-5 Protein; Gap Junctions; Glycyrrhetinic Acid; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Peptides; Phenotype; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Recombinant Proteins; RNA Interference; RNA, Small Interfering; S100 Proteins; Signal Transduction; Stents; Sus scrofa; Time Factors; Tunica Intima

2008